Recent Updates
Recently added Catalysts
ZTS Positive Sentiment

Zoetis Announces Third Quarter 2026 Results; Highlights Progress Advancing Innovation Across Diversified Portfolio and Narrows Full Year 2026 Revenue Guidance, Raises Full Year 2026 Adjusted EPS Guidance

Key Takeaway: Zoetis Inc. announced its third-quarter 2026 results, reporting performance aligned with expectations. The company experienced pressure in the Companion Animal segment but saw growth in Livestock and Diagnostics. Zoetis also narrowed its full-year revenue guidance while raising its adjusted EPS guidance for 2026.

Market Sentiment Analysis

POSITIVE FACTORS

  • Zoetis reported third-quarter results in line with expectations.
  • Growth in Livestock and Diagnostics helped offset pressures.
  • Adjusted EPS guidance for full year 2026 has been raised.

Full Press Release Details

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the third quarter of 2026. "Our third-quarter performance was in line with our expectations. Continued pressure in Companion Animal was partially offset by growth in Livestock and Diagnostics, reflecting the breadth of our portfolio," said Kristin Peck, Chief Executive Officer of Zoetis. "We remain focused on defending our position and directing our reso

Frequently Asked Questions

What were Zoetis' Q3 2026 results?

Zoetis reported third-quarter results in line with expectations.

How did Livestock and Diagnostics perform?

Growth in Livestock and Diagnostics helped offset pressures in Companion Animal.

What changes were made to the revenue guidance?

Zoetis narrowed its full-year revenue guidance for 2026.

What is the adjusted EPS guidance for 2026?

Zoetis raised its adjusted EPS guidance for the full year 2026.

Last updated: Nov 5, 2026